Holen Sie sich die Stockscreener-App
43.40
3.49%
-1.57
Handel nachbörslich:
43.40
Schlusskurs vom Vortag:
$44.97
Offen:
$44.4
24-Stunden-Volumen:
13,033
Relative Volume:
0.36
Marktkapitalisierung:
$265.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.12M
KGV:
-18.87
EPS:
-2.3
Netto-Cashflow:
$-6.82M
1W Leistung:
-6.53%
1M Leistung:
+29.17%
6M Leistung:
+3.78%
1J Leistung:
+5,928%
1-Tages-Spanne:
$43.01
$44.58
1-Wochen-Bereich:
$43.01
$47.52
52-Wochen-Spanne:
$0.3438
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Firmenname
Monopar Therapeutics Inc
Sektor
Branche
Telefon
(847) 388-0349
Adresse
1000 SKOKIE BLVD SUITE 350, WILMETTE
Vergleichen Sie MNPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
43.40 | 275.00M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-19 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-01-28 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
What is the dividend policy of Monopar Therapeutics Inc. stockRetirement Planning Entry Points For Consistent Profits - jammulinksnews.com
What’s next for Monopar Therapeutics Inc. stock priceFree Risk Controlled Picks With Real Returns - Newser
Combining price and volume data for Monopar Therapeutics Inc.Conservative Investment Setup and Risk Analysis - Newser
Monopar Therapeutics Inc. stock trend outlook and recovery path Free Growth Based Investment Plan Guidance - Newser
How strong is Monopar Therapeutics Inc. company’s balance sheetSuperior returns - jammulinksnews.com
What are analysts’ price targets for Monopar Therapeutics Inc. in the next 12 monthsInvest confidently with professional guidance - jammulinksnews.com
Does Monopar Therapeutics Inc. stock perform well during market downturnsAchieve superior capital gains with smart trades - jammulinksnews.com
How many analysts rate Monopar Therapeutics Inc. as a “Buy”Invest confidently with real-time data analysis - jammulinksnews.com
What is the risk reward ratio of investing in Monopar Therapeutics Inc. stockMaster stock selection with insider knowledge - jammulinksnews.com
When is the best time to buy Monopar Therapeutics Inc. stockFree Stock Market Strategy Classes - Newser
What makes Monopar Therapeutics Inc. stock price move sharplyFree Stock Selection with 300% Return - Newser
Why Monopar Therapeutics Inc. stock attracts strong analyst attentionFree Predictions - metal.it
What drives Monopar Therapeutics Inc. stock priceAccelerated capital growth - PrintWeekIndia
Is Monopar Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional
Does Monopar Therapeutics Inc. stock pay reliable dividendsConsistent double returns - jammulinksnews.com
What analysts say about Monopar Therapeutics Inc. stockFree Stock Index Interpretation - Autocar Professional
Monopar Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Long Term Trading Analysis for (MNPR) - news.stocktradersdaily.com
Is TBMCR a good long term investmentExplosive trading opportunities - jammulinksnews.com
Technical Analysis: Sreeleathers Limited (535601)Tremendous portfolio expansion - jammulinksnews.com
Is Siddhi Acquisition Corp. Debt Equity Composite Units a good long term investmentMarket-crushing profits - jammulinksnews.com
Institutional Investors Control 29% of Monopar Therapeutics Inc. (NASDAQ:MNPR) and Were Rewarded Last Week After Stock Increased 23% - 富途牛牛
Las Vegas Sands Corp. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com
Best Stocks for Risk Averse Investors Market Trend Prediction ToolsFree Stock Chart Pattern Guide - jammulinksnews.com
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
What analysts say about Monopar Therapeutics Inc. stock outlook5x Profit Potential - Newser
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):